A current view on the phenotypic antibiotic resistance of leading pathogens in wounded patients during the war in Ukraine
Keywords:
Acinetobacter, Pseudomonas, antibiotics, sensitivity, resistance, multidrug resistanceAbstract
Background and aim: The purpose of this study was to determine the effectiveness of antibacterial drugs through cluster analysis of antibiotic sensitivity data from clinical isolates of Acinetobacter and Pseudomonas spp., obtained from soft tissue wounds and burn injuries. Methods: The cohort included 76 clinical isolates of Gram-negative bacteria obtained from patients with combined injuries of soft tissues and burns. The final identification of the obtained isolates was carried using MALDI-ToF (Bruker). The sensitivity of clinical isolates to antibacterial drugs was determined using the standard Kirby-Bauer method. Extended antimicrobial susceptibility testing was performed to measure the minimal inhibitory concentrations of antibiotics against the studied. A hierarchical cluster analysis was performed using the Ward method. Results: The high level of resistance formation was observed among representatives of this Acinetobacter genus. We found the highest level of resistance in P. aeruginosa to ciprofloxacin. The lowest proportions of resistant Pseudomonas spp. were observed for meropenem and tobramycin. Cluster analysis of susceptibility data for P. aeruginosa isolates resulted in the division of antibiotics into two clusters with a significant dissimilarity distance. The isolated A. baumannii strains showed susceptible to a higher number of antibacterial drugs compared to P. aeruginosa. Conclusions: Clinical isolates of A. baumannii and P. aeruginosa obtained from patients with combined soft tissue injuries and burns in Ukraine in 2022 exhibit a high level of multidrug resistance. Cluster analysis results indicate that only tobramycin potentially retains efficacy against A. baumannii isolates. Clinical isolates of P. aeruginosa demonstrate susceptible to tobramycin and meropenem.
References
Antimicrobial resistance. Key facts [document on the Internet]. WHO; 2021 [cited 2023 May 27]. Available from: https://www.who.int/news-room/fact-sheets/detail/ antimicrobial-resistance
Disruption of access to medicines and medical devices in Ukraine, February–June 2022. Copenhagen: WHO Regional Office for Europe; 2022. Licence: CC BY-NC-SA 3.0 IGO.
Calhoun JH, Murray CK, Manring MM. Multidrug-resistant organisms in military wounds from Iraq and Afghanistan. Clin Orthop Relat Res. 2008;466(6):1356-62. doi: 10.1007/s11999-008-0212-9.
Gautham M. The double crisis of antimicrobial resistance in humanitarian settings. Antimicrobial resistance centre [Internet]. 2022 April 26 [cited 2023 May 27]. Available from: https://www.lshtm.ac.uk/research/centres/amr/news/341576/double-crisis-
Nazarchuk O, Dmyrtriiev D, Babina Y, Faustova M, Burkot V. Research of the activity of local anesthetics and antiseptics regarding clinical isolates of Acinetobacter baumannii as pathogens of postoperative infectious complications. Acta Biomed. 2022;93(1):e2022003. doi: 10.23750/abm.v93i1.11842.
Shaprynskyi V, Nazarchuk O, Faustova M, et al. Some aspects of infectious complications in patients with surgical diseases. [Internet] Multycentr Trials. Lek Obzor. 2020;69(7-8):257-60. Available from: https://www.researchgate.net/publication/342946513 Some aspects of infectious complications in patients with surgical diseases - Niektore aspekty infekcnych komplikacii u pacientov s chirurgickymi chorobami Multicentricka studia
Ibrahim S, Al-Saryi N, Al-Kadmy IMS, Aziz SN. Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals. Mol Biol Rep. 2021;(10):6987-98. doi: 10.1007/s11033-021-06690-6.
Eastridge BJ, Jenkins D, Flaherty S, Schiller H, Holcomb JB. Trauma system development in a theater of war: Experiences from Operation Iraqi Freedom and Operation Enduring Freedom. J Trauma. 2006 Dec;61(6):1366-72; discussion 1372-3. doi: 10.1097/01.ta.0000245894.78941.90. PMID: 17159678.
Michalopoulos A, Falagas ME. Treatment of Acinetobacter infections. Expert Opin Pharmacother. 2010;11(5):779-88. doi: 10.1517/14656561003596350.
Murtagh F, & Legendre P. Ward’s hierarchical agglomerative clustering method: which algorithms implement Ward’s criterion? J Classif. 2014;31(3): 274-295. https://doi.org/10.1007/s00357-014-9161-z.
Ljungquist O, Nazarchuk O, Kahlmeter G, et al. Highly multidrug-resistant Gram-negative bacterial infections in war victims in Ukraine, 2022. Lancet Infect Dis. 2023;23(7):784-6. doi: 10.1016/S1473-3099(23)00291-8.
European Committee on Antimicrobial Susceptibility Testing. European antimicrobial breakpoints. Basel: EUCAST (2022) https://eucast.org/clinical_breakpoints/ [Accessed January 10, 2023].
World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-4. doi: 10.1001/jama.2013.281053.
Global antimicrobial resistance and use surveillance system (GLASS) report 2022. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.
Chokshi A, Sifri Z, Cennimo D, Horng H. Global Contributors to Antibiotic Resistance. J Glob Infect Dis. 2019;11(1):36-42. doi: 10.4103/jgid.jgid_110_18. Erratum in: J Glob Infect Dis. 2019;11(3):131.
Hrabák J, Študentová V, Adámková V, et al. Report on a transborder spread of carbapenemase-producing bacteria by a patient injured during Euromaidan, Ukraine. New Microbes New Infect. 2015;8:28-30. doi: 10.1016/j.nmni.2015.09.005.
Haque U, Naeem A, Wang S, et al. The human toll and humanitarian crisis of the Russia-Ukraine war: the first 162 days. BMJ Glob Health. 2022;7(9):e009550. doi: 10.1136/bmjgh-2022-009550.
Loban' G, Faustova M, Dobrovolska O, Tkachenko P. War in Ukraine: incursion of antimicrobial resistance. Ir J Med Sci. 2023:1–3. doi: 10.1007/s11845-023-03401-x.
Kondratiuk V, Jones BT, Kovalchuk V, et al. Phenotypic and genotypic characterization of antibiotic resistance in military hospital-associated bacteria from war injuries in the Eastern Ukraine conflict between 2014 and 2020. J Hosp Infect. 2021;112:69-76. doi: 10.1016/j.jhin.2021.03.020.
Higgins PG, Hagen RM, Podbielski A, Frickmann H, Warnke P. Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii Isolated from War-Injured Patients from the Eastern Ukraine. Antibiotics (Basel). 2020;9(9):579. doi: 10.3390/antibiotics9090579.
Nahaichuk VI, Nazarchuk OA, Osadchuk NI, Dmytriiev DV, Nazarchuk HH. The analytical prognosis of the susceptibility to aminoglycosides and doxycycline in acinetobacter baumannii isolated from burns of intensive care unit patients. Wiad Lek. 2018;71(3 pt 2):705-9. PMID: 29783252.
Titov I, Wunderink RG, Roquilly A, et al. A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study). Clin Infect Dis. 2021;73(11):e4539-e48. doi: 10.1093/cid/ciaa803.
AlAmri AM, AlQurayan AM, Sebastian T, AlNimr AM. Molecular Surveillance of Multidrug-Resistant Acinetobacter baumannii. Curr Microbiol. 2020;77(3):335-42. doi: 10.1007/s00284-019-01836-z. Epub 2019 Dec 12. PMID: 31832843.
Keskin H, Tekeli A, Dolapci İ, Öcal D. Klinik örneklerden izole edilen Acinetobacter baumannii suşlarında beta-laktamaz kaynaklı direncin moleküler karakterizasyonu [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].[Turkish]. Mikrobiyol Bul. 2014;48(3):365-76. PMID: 25052103.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Valentyn Kovalchuk, Kristian Riesbeck , Oleksandr Nazarchuk, Mariia Faustova, Dmytro Dmytriiev, Halyna Nazarchuk, Roman Chornopyshchuk, Bohdan Levchenko
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.